

Author: Jöhrer Karin Hofbauer Sebastian W Zelle-Rieser Claudia Greil Richard Hartmann Tanja N
Publisher: Informa Healthcare
ISSN: 1471-2598
Source: Expert Opinion on Biological Therapy, Vol.12, Iss.4, 2012-04, pp. : 425-441
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Rituximab for chronic lymphocytic leukemia
Expert Opinion on Biological Therapy, Vol. 12, Iss. 4, 2012-04 ,pp. :


By van der Hoorn M.A.W.G. van Luxemburg-Heijs S.A.P. van Bergen C.A.M. Bongaerts R. Willemze R. Falkenburg J.H.F.
Methods, Vol. 31, Iss. 2, 2003-10 ,pp. :


By Daflon-Yunes Nathalia Pinto-Silva Flavio Vidal Raphael Novis Bruna Berguetti Tandressa Lopes Raphael Polycarpo Carla Rumjanek Vivian
Molecular and Cellular Biochemistry, Vol. 383, Iss. 1-2, 2013-11 ,pp. :